Association Between Human Leukocyte Antigens and Graft-Versus-Host Disease Occurrence in Allogeneic Hematopoietic Stem Cell Transplantation - A 10-Year Experience on Iranian Patients

Overview

Journal Arch Iran Med

Specialty General Medicine

Date 2023 Aug 6

PMID 37543907

Authors

Mohsen Hamidpour

Elham Roshandel

Haniyeh Ghaffari Nazari

Ghazaleh Sankanian

Hossein Bonakchi

Maryam Salimi

Sina Salari

Affiliations

Soon will be listed here.

Abstract

Background: Human leukocyte antigen (HLA) molecules mediate critical roles in determining responsiveness or non-responsiveness of the immune system, especially in transplantation. Some studies have shown a possible association between certain HLA alleles and some allogeneic hematopoietic stem cell transplantation (allo-HSCT) outcomes such as acute/chronic graft-versus-host disease (aGVHD/cGVHD) and overall survival (OS). In the current study, we investigated any possible association of HLA subclasses and acute/chronic GVHD occurrence as well as OS in patients receiving HLA-matched sibling allo-HSCT.

Methods: We retrospectively evaluated the association of various HLA alleles with the incidence of aGVHD, cGVHD, and OS of 162 patients who received allo-HSCT from HLA-matched sibling between 2009-2018 at Taleghani hospital in Tehran.

Results: We found that the incidence of aGVHD grades II-IV was higher among patients who had HLA-B*07 (=0.031) and HLA-DRB1*07 (=0.052). The presence of HLA-A*01 was associated with 4.5-fold greater odds of incidence in the extensive-type of cGVHD (=0.009). Furthermore, HLA-A*03 (=0.089), HLA-B*13(=0.013), HLA-B*40 (=0.042), HLA-DRB1*02 (=0.074), and HLA-DRB1*04 (=0.039) were associated with a lower rate of OS.

Conclusion: This study suggests that certain HLA alleles might influence the incidence and severity of acute or chronic GVHD in the context of HLA-matched sibling allo-HSCT. In addition, some specific HLA alleles help predict OS in allo-HSCT recipients. These results might be helpful in estimating the incidence of aGVHD, cGVHD, and OS as well as designing personalized therapy.

References

Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E . Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence. Blood. 2005; 107(5):1970-3. DOI: 10.1182/blood-2005-05-1958. View

Gyurkocza B, Rezvani A, Storb R . Allogeneic hematopoietic cell transplantation: the state of the art. Expert Rev Hematol. 2010; 3(3):285-99. PMC: 2943393. DOI: 10.1586/ehm.10.21. View

Roy D, Perreault C . Major vs minor histocompatibility antigens. Blood. 2017; 129(6):664-666. DOI: 10.1182/blood-2016-12-754515. View

Hobo W, Broen K, van der Velden W, Greupink-Draaisma A, Adisty N, Wouters Y . Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2012; 19(2):274-82. PMC: 3553241. DOI: 10.1016/j.bbmt.2012.09.008. View

Franssen L, Roeven M, Hobo W, Doorn R, Oostvogels R, Falkenburg J . A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma. Bone Marrow Transplant. 2017; 52(10):1378-1383. DOI: 10.1038/bmt.2017.118. View

Claas F, Duquesnoy R . The polymorphic alloimmune response in clinical transplantation. Curr Opin Immunol. 2008; 20(5):566-7. DOI: 10.1016/j.coi.2008.08.001. View

Parkhideh S, Chegeni R, Mehdizadeh M, Roshandel E, Tavakoli F, Hajifathali A . Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation. Transfus Apher Sci. 2019; 59(2):102696. DOI: 10.1016/j.transci.2019.102696. View

Dendrou C, Petersen J, Rossjohn J, Fugger L . HLA variation and disease. Nat Rev Immunol. 2018; 18(5):325-339. DOI: 10.1038/nri.2017.143. View

Couriel D, Caldera H, Champlin R, Komanduri K . Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004; 101(9):1936-46. DOI: 10.1002/cncr.20613. View

10.

Dignan F, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P . Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012; 158(1):30-45. DOI: 10.1111/j.1365-2141.2012.09129.x. View

11.

Clark R, Hermans J, Madrigal A, Nachbaur D, Kropshofer G, Gratwohl A . HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia. Br J Haematol. 2001; 114(1):36-41. DOI: 10.1046/j.1365-2141.2001.02897.x. View

12.

Kim H, Park S, Im H, Kim D, Min W, Kim H . The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea. Int J Hematol. 2002; 76(3):267-71. DOI: 10.1007/BF02982797. View

13.

Ghasemi K, Parkhideh S, Kazemi M, Salimi M, Salari S, Nalini R . The role of serum uric acid in the prediction of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. J Clin Lab Anal. 2020; 34(7):e23271. PMC: 7370721. DOI: 10.1002/jcla.23271. View

14.

Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A . Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?. Transplant Proc. 2005; 36(10):3190-3. DOI: 10.1016/j.transproceed.2004.10.088. View

15.

Saunthararajah Y, Nakamura R, Nam J, Robyn J, Loberiza F, Maciejewski J . HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood. 2002; 100(5):1570-4. View

16.

Kuba A, Raida L . Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. Mediators Inflamm. 2018; 2018:9451950. PMC: 5896258. DOI: 10.1155/2018/9451950. View

17.

Petersdorf E . Which factors influence the development of GVHD in HLA-matched or mismatched transplants?. Best Pract Res Clin Haematol. 2017; 30(4):333-335. PMC: 5967625. DOI: 10.1016/j.beha.2017.09.003. View

18.

Bouma G, Crusius J, Oudkerk Pool M, Kolkman J, von Blomberg B, Kostense P . Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996; 43(4):456-63. DOI: 10.1046/j.1365-3083.1996.d01-65.x. View

19.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

20.

Ardakani M, Mehrpooya M, Mehdizadeh M, Beiraghi N, Hajifathali A, Kazemi M . Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial. Bone Marrow Transplant. 2019; 55(4):830-832. DOI: 10.1038/s41409-019-0623-0. View